Futu News reported on January 10 that the three major indices of Hong Kong stocks fell slightly. The Hang Seng Index fell 0.42%, the Science Index fell 0.43%, and the National Index fell 0.3%.
By the midday close, Hong Kong stocks had risen 673, down 966, and closed at 1,341.
On the sector side, TechNet shares had mixed ups and downs. Xiaomi fell nearly 2%, Tencent fell more than 1%, Alibaba fell slightly, Kuaishou rose more than 1%, Bilibili rose nearly 1%, and JD, Meituan, Baidu, and NetEase rose slightly.
Domestic housing stocks and property management stocks mostly declined. Greentown China fell nearly 2%, Ocean Group and Vanke fell more than 1%, Yuexiu Real Estate fell nearly 1%, and Country Garden rose more than 1%.
Auto stocks generally fell, with NIO falling more than 4%, Zero Sports by more than 2%, Great Wall Motors and Ideal Auto falling by nearly 2%, BYD shares falling by more than 1%, and Xiaopeng Motors falling slightly.
Pharmaceutical stocks rose sharply, with BaiGe Shenzhou up more than 6%, Pharmaceutical Biotech up nearly 4%, Genting Xinyao up more than 3%, Kangfang Biotech up nearly 3%, and Pharmaceutical Kangde up more than 2%.
Catering stocks rose partly, with Haidilao up more than 6%, Xiabuxiabu by more than 3%, and Nai Xue's tea rising by more than 1%.
Shipping stocks continued to fall, with COSCO Marine Holdings falling nearly 5%, Haifeng International falling more than 4%, COSCO Haineng falling nearly 3%, and Orient Overseas International falling more than 1%.
On the other side, semiconductor stocks, paper stocks, wind power stocks, and insurance stocks declined one after another, while China Life Insurance and China Taibao all fell by more than 2%.
In terms of individual stocks,$WUXI BIO (02269.HK)$It has risen by nearly 4%, overseas CRO order indicators have improved, and domestic demand is still bottoming out.
$EAST BUY (01797.HK)$It rose more than 2%, and Dong Yuhui's first broadcast of the new GMV broke 100 million.
$INNOVENT BIO (01801.HK)$With an increase of more than 4%, the first phase III clinical study of the weight loss drug Maxidopeptide reached the main end point and all key secondary endpoints.
$COSCO SHIP HOLD (01919.HK)$It fell nearly 5%, and net profit for the whole year is expected to decrease by about 78.4% year on year to 23.889 billion yuan.
$HAIDILAO (06862.HK)$With an increase of more than 6%, leading restaurants are expected to drive performance growth through store expansion.
Top 20 half-day turnover
Edit/Chris